Skip to main content

Der Beitrag der Biochemie zur Psychiatrischen Forschung und Therapie

  • Conference paper
  • 32 Accesses

Zusammenfassung

Vorstellungen über die Materie, aus welcher das Gehirn besteht, und welchen Änderungen sie während dessen Funktion unterworfen sein könnte, gab es natürlich schon früh in der Geschichte der Menschheit, und im weitesten Sinne ist das Konzept einer chemischen Ursache von Geisteskrankheiten wohl so alt wie die Geschichte der Medizin. Eine wichtige Voraussetzung jedoch, dieses Konzept systematisch zu analysieren und zu konkretisieren, nämlich eine genauere Kenntnis der chemischen Zusammensetzung des Hirns, wurde erst mit dem Entstehen und der Entwicklung der organischen Chemie und ihren analytischen Techniken geschaffen.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Blaschko H (1972) Catecholamines 1922–1971 (Chap.1). In: Eichler O, Farah A, Herken H, Welch AD (eds) Handb. exp. Pharmakol., Band XXXIII. Berlin, Springer pp 1–15

    Google Scholar 

  • Beckmann H, Goodwin FK (1975) Antidepressant response to tricyclics and urinary MHPG in unipolar patients: clinical response to imipramine or amitriptyline. Arch gen Psychiat 32: 17–21

    Article  PubMed  CAS  Google Scholar 

  • Bowers MB (1980) Biochemical processes in schizophrenia: an update. Schizophrenia Bull 6: 393–430

    Google Scholar 

  • Campbell JD (1953) Manic-depressive disease. Lippincott JB, Philadelphia

    Google Scholar 

  • Carlsson A, Lindquist M (1963) Effect of chlorpromazine and haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol Toxicol 20:140–144

    Article  CAS  Google Scholar 

  • Erspamer V (ed) (1965) Handb. exp. Pharmacol. Band XIX. Springer, Berlin

    Google Scholar 

  • Flor-Henry P (1976) Lateralized temporal-limbic dysfunction und psychopathology. Ann N Y Acad Sci 280: 777–795

    Article  PubMed  CAS  Google Scholar 

  • Garnett ES, Firnau G, Nahmias C, Lang AE, Ballinger McMaster J (1984) Intracerebral and quantitative measurement of intracerebral dopamine metabolism in health and disease. Clin Neuropharmacol 7 (Suppl.1): 530–531 (S 290)

    Google Scholar 

  • Garnett ES, Firnau G, Nahmias C (1983) Dopamine visualized in the basal ganglia of living man. Nature 305: 137–138

    Article  PubMed  CAS  Google Scholar 

  • Garnett S, Firnau G, Nahmias C, Chirakal R (1983) Striatal dopamine metabolism in living monkeys examined by positron emission tomography. Brain Res: 280: 169–171

    Article  PubMed  CAS  Google Scholar 

  • Hoffer A, Osmond H (1960) The chemical basis of clinical psychiatry. Thomas ChC, Springfield 111

    Google Scholar 

  • Horrobin DF (1977) Schizophrenia as a prostaglandin deficiency disease. Lancet I: 936–937

    Article  Google Scholar 

  • Kelwala S, Jones D, Sitaram N (1983) Monoamine metabolites as predictors of antidepressant response: a critique. Prog Neuro Psychopharmacol & Biol Psychiat 7: 229–240

    Article  CAS  Google Scholar 

  • Kety SS (1975) Biochemistry of the major psychoses (Chap.2.7). In: Freedman AM, Kaplan HI, Sadock BJ (eds) Comprehensive textbook of psychiatry. Williams & Wilkins, Baltimore pp 178–187

    Google Scholar 

  • Lapin IP, Oxenkrug GF (1969) Intensification of the central serotonergic processes as a possible determinant of the thymoleptic effort. Lancet I: 132–136

    Article  Google Scholar 

  • Lajtha A (ed) (1970) Handb. of Neurochemistry. Plenum Press, New York

    Google Scholar 

  • Mackay AV (1984) High dopamine in the left amygdala. Trends in Neurosci 7: 107–108

    Article  CAS  Google Scholar 

  • McIlwain H (1958) Chemical contributions, especially from the nineteenth century, to knowledge of the brain and its functioning. In: Poynter FN (ed) The brain and its functions. Blackwell Scientific Publications, Oxford, pp 167–186

    Google Scholar 

  • Muscettola G, Potter WZ, Pickar D, Goodwin, FK (1984) Urinary 3-methoxy-4-hydroxyphenylglycol and major affective disorders. Arch gen Psychiat 41: 337–342

    Article  PubMed  CAS  Google Scholar 

  • Pauling L (1968) Orthomolecular psychiatry. Science 160: 265 – 271

    Article  PubMed  CAS  Google Scholar 

  • Phelps ME (1984) Principles of biochemical assays with positron CT. Clin Neuropharmacol 7 (Suppl 1): 520–521 (S285)

    Google Scholar 

  • Post RM, Uhde TW, Ballenger JC, Bunney WE (1982) Carbamazepine, temporal lobe epilepsy, and manic-depressive illness. In: Koella WP, Trimble MR (eds) Temporal lobe epilepsy, mania, and schizophrenia and the limbic system. Karger, Basel, pp 117–156

    Google Scholar 

  • Ragheb M, Ban TA (1982) Prostaglandins and schizophrenia: a review. Prog Neuro Psychopharmacol Biol Psychiat 6: 87–93

    Article  CAS  Google Scholar 

  • Reynolds GP (1983) Increased concentrations and lateral asymmetry of amygdala dopamine in schizophrenia. Nature 305: 527–529

    Article  PubMed  CAS  Google Scholar 

  • Rodnight R (1983) Schizophrenia: some current approaches. J Neurochem 41: 12–21

    Article  PubMed  CAS  Google Scholar 

  • Schildkraut JJ (1965) The catecholamine hypothesis of affective disorders: A review of supporting evidence. Amer J Psychiat 122: 509–522

    PubMed  CAS  Google Scholar 

  • Siever LJ, Uhde TW, Jimerson DC, Kafka MS, Lake CR, Targum S, Murphy DL (1983) Clinical studies of monoamine receptors in the affective disorders and receptor changes with antidepressant treatment. Prog Neuro Psychopharmacol Biol Psychiat 7:249–261

    Article  CAS  Google Scholar 

  • Smythies JR (1984) The transmethylation hypotheses of schizophrenia reevaluated. Trends in Neurosci 7:45–47

    Article  CAS  Google Scholar 

  • Stevens JR, Livermore A (1978) Kindling of the mesolimbic dopamine system: animal model of psychosis. Neurology 28: 36–46

    PubMed  CAS  Google Scholar 

  • Swann AC, Maas JW, Hattox SE, Landis H (1980) Catecholamine metabolites in human plasma as indices of brain function: effects of debrisoquin. Life Sci 27: 1857–1862

    Article  PubMed  CAS  Google Scholar 

  • Wagner HN, Burns HD, Dannais RF, et al. (1983) Imaging dopamine receptors in the human brain by positron tomography. Science 221: 1264–1266

    Article  PubMed  CAS  Google Scholar 

  • Wagner HN, Wong DF, Dannals RF, et al. (1984) Effect of age on dopamine receptors in the human brain. Clin Neuropharmacol 7 (Suppl 1): 540–541

    Google Scholar 

  • Wagner HN, Wong DF, Dannals RF, et al. (1984) Effect of age on dopamine receptors in the human brain. Clin Neuropharmacol 7 (Suppl 1): (S 296)

    Article  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Waldmeier, P.C. (1986). Der Beitrag der Biochemie zur Psychiatrischen Forschung und Therapie. In: Heimann, H., Gaertner, H.J. (eds) Das Verhältnis der Psychiatrie zu ihren Nachbardisziplinen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70952-4_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-70952-4_6

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-16179-0

  • Online ISBN: 978-3-642-70952-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics